RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación
Artículo científico (JournalArticle)
Magneto-Fluorescent Mesoporous Nanocarriers for the Dual-Delivery of Ofloxacin and Doxorubicin to Tackle Opportunistic Bacterial Infections in Colorectal Cancer
[EN] Cancer-related opportunistic bacterial infections are one major barrier for successful clinical therapies, often correlated to the production of genotoxic factors and higher cancer incidence. Although dual anticancer and antimicrobial therapies are a growing therapeutic fashion, they still fall short when it comes to specific delivery and local action in in vivo systems. Nanoparticles are seen as potential therapeutic vectors, be it by means of their intrinsic antibacterial properties and effective delivery capacity, or by means of their repeatedly reported modulation and maneuverability. Herein we report on the production of a biocompatible, antimicrobial magneto-fluorescent nanosystem (NANO3) for the delivery of a dual doxorubicin-ofloxacin formulation against cancer-related bacterial infections. The drug delivery capacity, rendered by its mesoporous silica matrix, is confirmed by the high loading capacity and stimuli-driven release of both drugs, with preference for tumor-like acidic media. The pH-dependent emission of its surface fluorescent SiQDs, provides an insight into NANO3 surface behavior and pore availability, with the SiQDs working as pore gates. Hyperthermia induces heat generation to febrile temperatures, doubling drug release. NANO3-loaded systems demonstrate significant antimicrobial activity, specifically after the application of hyperthermia conditions. NANO3 structure and antimicrobial properties confirm their potential use in a future dual anticancer and antimicrobial therapeutical vector, due to their drug loading capacity and their surface availability for further modification with bioactive, targeting species., This work was funded by the Associate Laboratory for Green Chemistry-LAQV which is financed by national funds from FCT/MCTES (UIDB/50006/2020 and UIDP/50006/2020) as well as the Scientific Society PROTEOMASS (Portugal) for funding support (General Funding Grant 2021). G.M thanks to FCT/MEC (Portugal) for his doctoral grant PD/BD/142865/2018. E.O thanks FCT/MEC (Portugal) for the individual contract, CEECIND/00648/2017. This work was also funded by FCT-Foundation for Science and Technology, I.P., through projects UIDB/04077/2020, UIDP/04077/2020, OrMagNa-PTDC/NAN-MAT/28785/2017, BioISI-UID/Multi/04046/2019, UIDB/04046/2020 and UIDP/04046/2020 Centre grants (BioISI) and NECL infrastructure.
The authors also acknowledge the financial support from Project PROMETEO 2018/024 from the Generalitat Valenciana and Project RTI2018-100910-B-C41 funded by MCIN/AEI /10.13039/501100011033/ and FEDER A way to make Europe.
Proyecto:
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 RTI2018-100910-B-C41
,
Generalitat Valenciana / 3599-PPCDT PROMETEO/2018/024
,
Fundação para a Ciência e a Tecnologia / 6817 - DCRRNI ID PTDC/NAN-MAT/28785/2017
,
Portugal / 6817 - DCRRNI ID RTI2018-100910-B-C41-AR
,
Agencia Estatal de Investigación / 6817 - DCRRNI ID UID/Multi/04046/2019
,
Fundação para a Ciência e a Tecnologia / 6817 - DCRRNI ID PROMETEO2018/024
,
Portugal / 6817 - DCRRNI ID UIDB/04046/2020
,
Generalitat Valenciana / 6817 - DCRRNI ID General Funding Grant 2021
,
Fundação para a Ciência e a Tecnologia / 6817 - DCRRNI ID UIDB/04077/2020
,
Portugal / CEEC IND 2017 UIDB/50006/2020
,
Proteomass Scientific Society / OE UIDP/04046/2020
,
Fundação para a Ciência e a Tecnologia UIDP/04077/2020
,
Portugal UIDP/50006/2020
,
Fundação para a Ciência e a Tecnologia CEECIND/00648/2017/CP1462/CT0014
,
Portugal PD/BD/142865/2018